Valuation: Inter Pharma

Market Cap 300.25Cr 8.95Cr 7.99Cr 7.43Cr 6.76Cr 13Cr 866.05Cr 13Cr 89Cr 35Cr 441.54Cr 34Cr 33Cr 1.42TCr P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 312.18Cr 9.3Cr 8.31Cr 7.73Cr 7.03Cr 13Cr 900.46Cr 13Cr 93Cr 36Cr 459.08Cr 35Cr 34Cr 1.47TCr EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
14/08 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
11/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/03 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02/03 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
12/11 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
12/11 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/25/14 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/25/13 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/25/16 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/25/16 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/25/01 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
25/25/25 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/25/25 Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 CI
1 day+0.81%
1 week+0.81%
1 month+1.64%
3 months+1.64%
6 months+22.17%
Current year+7.83%
1 week 4.72
Extreme 4.72
4.98
1 month 4.72
Extreme 4.72
5.1
Current year 3.68
Extreme 3.68
5.65
1 year 3.44
Extreme 3.44
5.65
3 years 2.02
Extreme 2.02
7.3
5 years 2.02
Extreme 2.02
14.09
10 years 1.62
Extreme 1.617581
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 51 14/06/2017
Director/Board Member 64 01/08/2020
Director/Board Member 56 01/02/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/26 Buy

Chief Executive Officer

60,000 0.0099%
21/05/26 Buy

Chief Executive Officer

60,000 0.0099%
20/05/26 Buy

Chief Executive Officer

22,600 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+0.81%+20.98%-18.59% 8.95Cr
+0.83%+3.19%+37.87%+106.25% 1,05100Cr
+1.93%+2.11%+36.82%+64.90% 63TCr
+1.49%+5.19%+19.84%+85.41% 49TCr
+2.26%+0.90%+66.40%+39.33% 36TCr
+1.45%+3.50%+21.87%+42.64% 34TCr
+1.17%+2.37%+11.71%+35.14% 27TCr
+0.89%+1.08%-7.28%+10.52% 25TCr
+1.82%+2.94%+40.43%+52.78% 22TCr
+2.77%+4.44%+29.49%+101.40% 19TCr
Average +1.43%+2.40%+27.81%+51.98% 38.04TCr
Weighted average by Cap. +1.20%+2.44%+31.57%+69.96%

Financials

2024 2025
Net sales 191.19Cr 5.7Cr 5.09Cr 4.73Cr 4.31Cr 8.13Cr 551.48Cr 8.17Cr 57Cr 22Cr 281.16Cr 21Cr 21Cr 902.27Cr 221.41Cr 6.6Cr 5.89Cr 5.48Cr 4.99Cr 9.42Cr 638.63Cr 9.46Cr 66Cr 26Cr 325.59Cr 25Cr 24Cr 1.04TCr
Net income 3.73Cr 11.11L 10L 9L 8L 15.85L 11Cr 15.92L 1.11Cr 43.53L 5.48Cr 41.72L 40.81L 18Cr 12Cr 36.47L 32.57L 30.3L 27.56L 52.04L 35Cr 52.27L 3.65Cr 1.43Cr 18Cr 1.37Cr 1.34Cr 58Cr
Net Debt 21Cr 62.26L 55.61L 51.73L 47.05L 88.84L 60Cr 89.23L 6.23Cr 2.44Cr 31Cr 2.34Cr 2.29Cr 99Cr 12Cr 35.55L 31.75L 29.54L 26.87L 50.73L 34Cr 50.95L 3.56Cr 1.39Cr 18Cr 1.34Cr 1.31Cr 56Cr
Projected Income Statement - Annual - Inter Pharma
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
09/26/09 THB 4.960 +0.81% 76,220
08/26/08 THB 4.920 0.00% 35,310
07/26/07 THB 4.920 +0.41% 93,600
06/26/06 THB 4.900 0.00% 4,30,642
05/26/05 THB 4.900 -0.41% 2,48,432

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Inter Pharma